Levi & Korsinsky notifies investors that it has commenced an investigation into ETHZilla Corporation (NASDAQ : ETHZ) concerning potential violations of the federal securities laws.
On December 19, 2025, ETHZilla disclosed it had sold approximately 24,291 Ether (ETH) for an aggregate of $74.5 million, that it expects to use all, or a significant portion, of this funding to redeem its outstanding senior secured convertible notes, and that it "plans to continue to evaluate various capital raising strategies including ETH sales and equity offerings, as it seeks to complete its business plans, including the tokenization of real world assets." Then, during pre-market hours on December 22, 2025, the Company disclosed that "[i]n the future, the Company believes its value will be driven by revenue and cash flow growth from our RWA tokenization business." Following this news, ETHZilla's stock price fell over 8% on December 22, 2025.
If you suffered a loss on your ETHZilla Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into AST SpaceMobile, Inc. (NASDAQ: ASTS) concerning potential violations of the federal securities laws.
On December 15, 2025, it was revealed that AST’s launch of its BlueBird 6 was delayed. The launch, which was scheduled for December 15, 2025, was tentatively pushed back to December 21, 2025. AST’s BlueBird 6, the Company’s next-generation satellite, was scheduled to launch at the Satish Dhawan Space Center in India on December 15, 2025. The launch was reportedly delayed by the Indian Space Research Organisation (ISRO) due to necessary, prolonged pre-launch integration and testing. AST has yet to release a detailed public statement pertaining to the delay. Following this news, AST’s stock price fell by $6.51 (9.52%) per share to close at $61.86 per share on December 17, 2025.
If you suffered a loss on your AST SpaceMobile, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Above Food Ingredients Inc. (NASDAQ: ABVE) concerning potential violations of the federal securities laws.
Above Food revealed on December 12, 2025, that “the timetable” of its fiscal year 2025 audit “has been impacted over the past several weeks by unavoidable illness-related resourcing challenges faced by the team” and would not be completed on time. The Company stated that it “has notified Nasdaq accordingly and has applied for the 180-day extension.” Following this news, Above Food’s stock price fell over 43% on December 15, 2025.
If you suffered a loss on your Above Food Ingredients Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Maplebear Inc. (NASDAQ: CART) concerning potential violations of the federal securities laws.
On December 10, 2025, a report accused the company of charging different prices for the same items, including showing several different prices for users who added the same item from the same store at the same time. The report, led by Consumer Reports, progressive think tank Groundwork Collaborative, and progressive media outlet More Perfect Union, pointed to potential harm to customer trust. Following this news, Instacart stock fell.
If you suffered a loss on your Maplebear Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Genesco Inc. (NYSE: GCO) concerning potential violations of the federal securities laws.
Genesco reported it's third quarter results on December 4, 2025, and stated that: “Based primarily on the margin pressure at Schuh and our more cautious view on sales, we are revising our full year outlook and now expect adjusted earnings per share of approximately $0.95.” Following this news, the price of the Company’s stock fell.
If you suffered a loss on your Genesco Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Oxford Industries, Inc. (NYSE: OXM) concerning potential violations of the federal securities laws.
On December 10, 2025, after the market closed, Oxford published third quarter results for fiscal 2025 showing decreased gross margin and $61 million noncash impairment charges primarily relating to its Johnny Was trademark. Management attributed the decline to consumer preferences and demand patterns, as well as continuing tariff pressures. As a result, Oxford slashed its full-year sales and adjusted EPS guidance from $1.52B down to $1.47B - $1.49B. Following this news, OXM’s stock price fell over 20% to open at $32.40 per share.
If you suffered a loss on your Oxford Industries, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Rezolute, Inc. (NASDAQ: RZLT) concerning potential violations of the federal securities laws.
On December 11, 2025, before the market opened, Rezolute announced topline results from its Phase 3 sunRIZE study evaluating ersodetug in patients with congenital hyperinsulinism. The company reported that the study did not meet its primary endpoint, as it “was not statistically significant to the placebo group, which experienced a 40% improvement.”. Further, the study did not meet its key secondary endpoint which was also “not statistically significant to the placebo.” Management expressed disappointment noting “we are conducting a thorough evaluation to gain a better understanding of the study outcomes.” Following this news, RZLT’s stock price fell over 89% to open at $1.21 per share.
If you suffered a loss on your Rezolute, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Logitech International S.A. (NASDAQ: LOGI) concerning potential violations of the federal securities laws.
Logitech issued a press release on November 14, 2025, announcing that "the Company recently experienced a cybersecurity incident relating to the exfiltration of data" and "promptly took steps to investigate and respond, with the assistance of leading external cybersecurity firms." The press release further stated that "[w]hile the investigation is ongoing, at this time Logitech believes that the unauthorized third party used a zero-day vulnerability in a third-party software platform and copied certain data from the internal IT system" and that "[t]he data likely included limited information about employees and consumers, and data relating to customers and suppliers." Following this news, Logitech's stock price fell over 4% on November 17, 2025
If you suffered a loss on your Logitech International S.A. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Village Farms International, Inc. (NASDAQ: VFF) concerning potential violations of the federal securities laws.
Village Farms issued a press release on December 2, 2025, disclosing that it "received notice that it was not awarded a conditional medical license as part of the Phase I license awards granted by the Texas Department of Public Safety (DPS) on December 1, 2025." Following this news, Village Farms' stock price fell over 9% on December 2, 2025.
If you suffered a loss on your Village Farms International, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Caledonia Mining Corporation Plc (NYSE: CMCL) concerning potential violations of the federal securities laws.
Caledonia disclosed on December 1, 2025, that proposed changes to Zimbabwe's 2026 gold mining royalty and tax regimes could reduce profitability and cash flow at its Blanket Mine, potentially falling short of current market expectations. Following this news, Caledonia Mining's stock price fell over 14% on December 1, 2025.
If you suffered a loss on your Caledonia Mining Corporation Plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into HelloFresh SE (OTC: HELFY) concerning potential violations of the federal securities laws.
Grizzly Research published a report on November 6, 2025, alleging that HelloFresh's "business is now in sharp decline, with management seemingly prioritizing self-enrichment at shareholders' expense." Specifically, the report states that customer demand has declined while the Company's CEO has "extracted cash by pledging HelloFresh shares as collateral for bank loans" for real estate investments managed by his brother. Following this news, HelloFresh's stock price dropped on the same day.
If you suffered a loss on your HelloFresh SE securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Cigna Group (NYSE: CI) concerning potential violations of the federal securities laws.
On October 30, 2025, before the market opened, CI published third quarter 2025 earnings results highlighting the company’s performance expectations for the coming years. CI disclosed its Healthcare MCR was 84.8% for third quarter 2025 compared to 82.8% for third quarter 2024, reducing the Company’s future profitability. Management attributed it to the Company’s Individual and Family Plans business and higher stop loss medical costs relative to the prior year. In direct response to this news, CI’s stock price fell by $52.02 (17%) per share to close at $247.10 per share on October 30, 2025.
If you suffered a loss on your The Cigna Group securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Ventyx Biosciences, Inc. (NASDAQ: VTYX) concerning potential violations of the federal securities laws.
Ventyx issued a press release on December 2, 2025, "providing an update to its ongoing Phase 2 study of VTX2735 in patients with recurrent pericarditis (‘RP')." In relevant part, the Company's Chief Executive Officer said that "[w]e are . . . revising our guidance for topline data release from the interim analysis of the Phase 2 RP trial to Q1 2026," describing the shift as "providing us with an opportunity to introduce dose-ranging studies with our new once-daily or QD formulation in the current Phase 2 study while also expanding into Canada, EU and the UK, a strategy we feel will accelerate Phase 3 timelines." Following this news, Ventyx's stock price fell over 15% on December 2, 2025.
If you suffered a loss on your Ventyx Biosciences, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Alaska Air Group, Inc. (NYSE: ALK) concerning potential violations of the federal securities laws.
Alaska Airlines disclosed on October 23, 2025, that it was "experiencing an IT outage that has resulted in a systemwide ground stop of Alaska and Horizon Air flights across our network, causing delays and cancellations." Following this news, Alaska Air's stock price fell over 6% on October 24, 2025.
If you suffered a loss on your Alaska Air Group, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Iron Mountain Incorporated (NYSE: IRM) concerning potential violations of the federal securities laws.
On November 19, 2025, Gotham City Research published a report alleging that the company understates its leverage, inflates adjusted EBITDA through recurring add-backs, and masks declining core volumes with aggressive price increases. Gotham City Research also cites customer lawsuits accusing IRM of imposing sharply higher fees and “ransom-like” practices tied to record retrieval and destruction. Following this news, shares of Iron Mountain fell over 5% on the same day.
If you suffered a loss on your Iron Mountain Incorporated securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Owens Corning (NYSE: OC) concerning potential violations of the federal securities laws.
Owens Corning issued a press release on November 5, 2025, announcing its financial results for the third quarter of 2025. Among other items, Owens Corning reported a net loss of $495 million, or $5.93 per diluted share, compared to net income of $287 million, or $3.26 per share, for the same period in 2025. The net loss reflected a $780 million non-cash impairment charge tied to the Company's doors business. Owens Corning projected that soft residential markets and reduced storm-related roofing demand will weigh on fourth-quarter results, with revenue expected to decline to between $2.1 billion and $2.2 billion. Following this news, Owen Corning's stock price fell over 9% on November 5, 2025.
If you suffered a loss on your Owens Corning securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Waldencast plc (NASDAQ: WALD) concerning potential violations of the federal securities laws.
Waldencast issued a press release reporting its financial results for the second quarter of 2025 on November 24, 2025. The Company updated its financial outlook for the full year of 2025, expecting net revenue to be broadly in line with 2024 and adjusted EBITDA margin in the high single digits. Previously, Waldencast had guided to mid-teens net revenue growth and an adjusted EBITDA margin in the mid-to-high teens. The Company also reported a net loss of $185.2 million for the first half of 2025, primarily driven by impairment charges of $132.1 million and $20 million on its Obagi Medical and Milk Makeup brands, respectively. Following this news, Waldencast's share price fell over 6% on November 24, 2025.
If you suffered a loss on your Waldencast plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Nutanix, Inc. (NASDAQ: NTNX) concerning potential violations of the federal securities laws.
On November 25, 2025, after the market closed, Nutanix published first quarter fiscal 2026 revenue results that landed at the bottom end of the Company’s prior guidance. Management attributed the decline to a late quarter “revenue shift from Q1 to future periods” caused by increased customer demand for flexible start dates and the growth of the company’s business through third-party OEM partners. As a result, Nutanix slashed its full-year revenue projection from $2.9B - $2.94B down to $2.82B - $2.86B. Following this news, NTNX’s stock price fell by $10.43 (17.7%) per share to close at $48.34 per shar on November 26, 2025.
If you suffered a loss on your Nutanix, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into PagerDuty, Inc. (NYSE: PD) concerning potential violations of the federal securities laws.
On the evening of November 25, 2025, PagerDuty published results for the third quarter of fiscal 2026, disclosing a reduction in dollar-based net retention compared to the prior quarter. Management resultantly lowered its full-year revenue projections, conceding they had previously “underestimated the current headwinds to retention … the dollar value of the contraction, driven by seat-based reductions and customer budget caution has been larger than we forecast.” Following this news, PD’s stock price fell by $3.54 (23.7%) per share to close at $11.64 per share on November 26, 2025.
If you suffered a loss on your PagerDuty, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into SCHMID Group N.V. (NASDAQ: SHMD) concerning potential violations of the federal securities laws.
Schmid issued a press release on November 17, 2025, disclosing receipt of a staff determination letter from the Nasdaq's Listing Qualifications Department, advising the company of the staff's decision "to delist the Company's ordinary shares and warrants from Nasdaq unless the Company timely appeals the staff's determination," due to the Company's failure to file its annual report for 2024. Following this news, Schmid's stock price fell over 31% on November 18, 2025.
If you suffered a loss on your SCHMID Group N.V. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Venu Holding Corporation (NYSE: VENU) concerning potential violations of the federal securities laws.
On November 14, 2025, Venu issued a press release reporting its financial results for the third quarter of 2025. Among other items, Venu reported revenue of $5.38 million, representing a 1.3% year-over-year decline and missing consensus estimates by $2.05 million. Following this news, Venu's stock price fell over 21% on November 17, 2025.
If you suffered a loss on your Venu Holding Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Sanara MedTech Inc. (NASDAQ: SMTI) concerning potential violations of the federal securities laws.
On November 11, 2025, Sanara announced that it would be “discontinuing operations of [its Tissue Health Plus (“THP”) program] to improve its operating efficiency and reallocate resources to its core surgical business.” The following day, before market hours, Sanara released its third quarter 2025 financial results, reporting that its “net loss from discontinued operations . . . was $31.2 million,” which “includes a noncash asset impairment charge of $26.5 million . . . related to the discontinued operations of THP.” Following this news, Sanara’s stock price fell over 24% on November 12, 2025.
If you suffered a loss on your Sanara MedTech Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Jayud Global Logistics Ltd. (NASDAQ: JYD) securities.
If you suffered a loss on your Jayud Global Logistics Ltd. investment and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
THE LAWSUIT: Apr 21 2023 - Apr 30 2025
CASE DETAILS: The filed complaint alleges that Jayud Global Logistics Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) Jayud was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; (3) Jayud’s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Home Depot, Inc. (NYSE: HD) concerning potential violations of the federal securities laws.
On November 18, 2025, Home Depot published a press release announcing third quarter 2025 fiscal results and updated fiscal 2025 guidance. The Company’s CEO disclosed that Home Depot’s results missed management’s expectations for the third quarter, at least partially due to a lack of expected demand. As a result, Home Depot also tightened its full-year guidance for 2025. Following this news, Home Depot’s stock price fell over 6% to close at $336.48 per share on November 18, 2025.
If you suffered a loss on your The Home Depot, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Gauzy Ltd. (NASDAQ: GAUZ) concerning potential violations of the federal securities laws.
Gauzy announced on November 14, 2025, that the Company "will not be releasing its financial results for the third quarter of 2025 on November 14 as previously planned." The press release explained that "[t]he reason for the delay is that, during a hearing held on November 13, 2025, the Commercial Court of Lyon, France, ordered the commencement of French law insolvency proceedings ('Redressement Judiciaire') relating to three subsidiaries of Gauzy located in France." Following this news, Gauzy's stock price fell over 33% on November 14, 2025.
If you suffered a loss on your Gauzy Ltd. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into IperionX Limited (NASDAQ: IPX) concerning potential violations of the federal securities laws.
Spruce Point published a short report on November 12, 2025, expressing concerns with IperionX’s financial reporting, stating it “has identified some financial reporting issues that appear to affect operating cash flows.” Following this news, the price of IperionX’s stock dropped.
If you suffered a loss on your IperionX Limited securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into VirTra, Inc. (NASDAQ: VTSI) concerning potential violations of the federal securities laws.
VirTra issued a press release on November 10, 2025, reporting its financial results for the third quarter of 2025. Among other items, VirTra reported GAAP earnings per share of -$0.03, missing the consensus estimate by $0.07, and revenue of $5.3 million, missing consensus by $1.69 million. The Company's Chief Executive Officer said that the Company "continued to work through a slower federal funding cycle" and that "[t]he timing of federal awards and customer acceptances affected near-term revenue recognition." Following this news, Virtra's stock price fell over 7% on November 11, 2025.
If you suffered a loss on your VirTra, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Alibaba Group Holding Limited (NYSE: BABA) concerning potential violations of the federal securities laws.
Reuters published an article on November 14, 2025, entitled “White House says Alibaba is helping Chinese military target US, FT reports.” The article stated that Alibaba had been accused of “providing technological support for Chinese military operations against targets in the United States, the Financial Times said on Friday, citing a White House memo.” Following this news, Alibaba American Depositary Shares fell in intraday trading on the same day.
If you suffered a loss on your Alibaba Group Holding Limited securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Bicycle Therapeutics plc (NASDAQ: BCYC) concerning potential violations of the federal securities laws.
On October 31, 2025, RBC Capital Markets analyst Leonid Timashev downgraded Bicycle to Sector Perform from Outperform, citing delays in development of zelenectide pevedotin, which is in phase 2/3 development for metastatic urothelial cancer, due to pushing dose selection to the first quarter of 2026. Timashev noted that the urothelial cancer treatment space is growing more competitive, and asserted that any further delays from Bicycle will only help sales of a competing Pfizer product. Following this news, Bicycle's American Depositary Receipt ("ADR") price fell over 7% on the same day.
If you suffered a loss on your Bicycle Therapeutics plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Zimmer Biomet Holdings, Inc. (NYSE: ZBH) concerning potential violations of the federal securities laws.
Zimmer Biomet issued a press release on November 5, 2025, announcing its financial results for the third quarter of 2025 and held an earnings call to discuss the same. Among other items, Zimmer Biomet reported net sales of $2 billion, missing consensus estimates of $2.01 billion. Zimmer Biomet also lowered the top end of its outlook for full-year organic revenue growth, projecting gains of 3.5% to 4%, compared to a previous range of 3.5% to 4.5%. Zimmer Biomet reported weakness in international markets and non-core businesses, while its Chief Executive Officer said that distributor challenged and a cancelation of orders in the Middle East and Eastern Europe also weighed on the Company's results. Analysts also noted lower-than-expected growth in U.S. knee and hip replacement sales, expressing concerns about Zimmer Biomet's operational controls. Following this news, Zimmer Biomet's stock price fell over 15% on November 5, 2025.
If you suffered a loss on your Zimmer Biomet Holdings, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Prelude Therapeutics Incorporated (NASDAQ: PRLD) concerning potential violations of the federal securities laws.
Prelude issued a press release on November 4, 2025, announcing its decision to pause the clinical development of its SMARCA2 degrader program. Prelude said that "[t]he decision to pause was based on a comprehensive review of clinical data generated to date and the Company's assessment of the capital and resource allocation required to advance the SMARCA2 program, versus the JAK2 and KAT6A programs, to key points of value inflection." Following this news, Prelude's stock price fell over 55% on November 4, 2025.
If you suffered a loss on your Prelude Therapeutics Incorporated securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Alkami Technology, Inc. (NASDAQ: ALKT) concerning potential violations of the federal securities laws.
Alkami issued a press release on October 30, 2025, reporting its financial results for the third quarter of 2025. Among other items, Alkami reported GAAP earnings per share of -$0.14, missing consensus estimates by $0.02, and revenue of $113 million, missing consensus estimates by $0.48 million. Following this news, Alkami's stock price fell over 7% on October 31, 2025.
If you suffered a loss on your Alkami Technology, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Savers Value Village, Inc. (NYSE: SVV) concerning potential violations of the federal securities laws.
On or around June 29, 2023, Savers conducted its initial public offering ("IPO") of 25,635,415 shares of common stock priced at $18.00 per share. On October 30, 2025, Savers reported its financial results for the third quarter. Although Savers reported a non-GAAP $0.14 per share profit, its financial results actually reflected a loss of $0.09 per share calculated according to GAAP. Following this news, Savers' stock price fell over 30% on October 31, 2025.
If you suffered a loss on your Savers Value Village, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Alvotech (NASDAQ: ALVO) concerning potential violations of the federal securities laws.
On November 2, 2025, Alvotech published a press release notifying investors that the Company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its Biologics License Application (BLA) for ATV05. The CRL noted that certain deficiencies must be resolved before the BLA for ATV05 can be approved. Alvotech had submitted a Corrective and Preventive Action (CAPA) plan to the FDA following a previous inspection of the Company’s facility. Management stated that Alvotech is “disappointed” in receiving the CRL. Following this news, Alvotech’s stock price fell over 34.2% to close at $5.03 per share on November 3, 2025.
If you suffered a loss on your Alvotech securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Hormel Foods Corporation (NYSE: HRL) concerning potential violations of the federal securities laws.
The Wall Street Journal published an article on October 29, 2025, entitled “Hormel Cuts Forecast on Price Pressure, Consumer Backdrop; Parts Ways With CFO.” The article stated that Hormel “warned earnings in the latest quarter were squeezed by price pressures, bird flu and a fire that damaged its Arkansas peanut butter production facility. The company also said it was parting ways with its top finance executive[.]” Following this news, Hormel Foods stock fell over 9% on October 29, 2025.
If you suffered a loss on your Hormel Foods Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Camping World Holdings, Inc. (NYSE: CWH) concerning potential violations of the federal securities laws.
Camping World issued a press release on October 28, 2025, announcing its financial results for the third quarter of 2025. Among other items, the press release disclosed that "the Company's management identified prior period misstatements related to the measurement of the realizable portion of the Company's outside basis difference deferred tax asset in CWGS Enterprises, LLC[.]" Accordingly, Camping World revised its 2024 annual report, increasing its reported deferred tax assets by $43.8 million. Following this news, Camping World's stock price fell over 24% on October 29, 2025.
If you suffered a loss on your Camping World Holdings, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Akebia Therapeutics, Inc. (NASDAQ: AKBA) concerning potential violations of the federal securities laws.
On October 29, 2025, Akebia announced that it will not pursue the VALOR trial for Vafseo label expansion in non-dialysis chronic kidney disease patients due to FDA Type C meeting feedback requiring a significantly larger patient population, increasing time and costs. Following this news, AKBA’s stock price fell over 31% to open at $2.12 per share.
If you suffered a loss on your Akebia Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Nidec Corporation (OTC: NJDCY) concerning potential violations of the federal securities laws.
Nidec published a press release on October 23, 2025, announcing that it was withdrawing its year end forecast, and had decided not to pay a surplus dividend as “investigations by the Third Party Committee regarding suspected inappropriate accounting practices involving the Company and its group, as well as other internal investigations, are ongoing.” Then, on October 27, 2025, the Tokyo Stock Exchange (“TSE”) designated Nidec under a Special Security alert in part because “TSE deems that the improvement of the internal management system of said listed company is highly necessary.” The alert noted that “[s]ince the initial issue was discovered, the scope of the investigation has continued to expand” and that “deficiencies have already been identified in the Company’s company-wide internal control systems (particularly in areas related to information and communication), as well as in the internal controls related to its accounting and financial closing processes.” Following this news, Nidec’s stock price fell over 20% on October 27, 2025.
If you suffered a loss on your Nidec Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Jefferies Financial Group Inc. (NASDAQ: JEF) concerning potential violations of the federal securities laws.
On October 8, 2025, Jefferies announced that it and Point Bonita had approximately $715 million in exposure to First Brands' receivables, which represents roughly 25% of Point Bonita's trade finance portfolio. Following this news, the price of Jefferies stock fell over 8% on October 8, 2025.
If you suffered a loss on your Jefferies Financial Group Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Braskem S.A. (NYSE: BAK) concerning potential violations of the federal securities laws.
Braskem announced on September 26, 2025, "that it has retained financial and legal advisors to support the Company in preparing a diagnosis of economic-financial alternatives to optimize its capital structure." Following this news, Braskem's American Depositary Receipt ("ADR") price fell over 14% on September 26, 2025.
If you suffered a loss on your Braskem S.A. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) concerning potential violations of the federal securities laws.
Arcturus issued a press release on October 22, 2025, "announc[ing] interim results from its ongoing Phase 2 clinical trial of ARCT-032, an investigational inhaled mRNA therapy for people with cystic fibrosis." The press release disclosed that patients in the trial had not shown a meaningful improvement in forced expiratory volume for one second, or FEV1, a key test for the health of cystic fibrosis patients. Following this news, Arcturus's stock price fell over 50% on October 22, 2025.
If you suffered a loss on your Arcturus Therapeutics Holdings Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into American Battery Technology Company (NASDAQ: ABAT) concerning potential violations of the federal securities laws.
On October 15, 2025, American Battery disclosed in a filing with the U.S. Securities and Exchange Commission that the U.S. Department of Energy ("DoE") had terminated its grant for the construction of a commercial scale facility for the manufacturing of battery cathode grade lithium hydroxide. Under the grant, the DoE would have contributed $57.7 million towards the facility, while the Company would have put in an equal amount. Following this news, American Battery's stock price fell over 57% on October 17, 2025.
If you suffered a loss on your American Battery Technology Company securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Jumia Technologies AG (NYSE: JMIA) concerning potential violations of the federal securities laws.
On October 17, 2025, Capital downgraded Jumia to Sell from Buy, citing concerns about Jumia's net working capital position. The Aletheia analyst considered Jumia's improvements in the metric to be temporary and unsustainable, and also noted that Jumia's stock is priced higher than peer e-commerce stocks in terms of enterprise value-to-sales ratio. Following this news, Jumia's American Depositary Receipt ("ADR") price fell over 9% on October 17, 2025.
If you suffered a loss on your Jumia Technologies AG securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Knight-Swift Transportation Holdings Inc. (NYSE: KNX) concerning potential violations of the federal securities laws.
On October 22, 2025, Knight-Swift published third quarter fiscal results for 2025. As part of the conference call, top management revealed that the company missed on its earnings per share (EPS) expectation by over 13.5%. Knight-Swift leadership also revealed that the company has not seen the expected seasonal lift across the platform heading into the holiday season. Following this news, Knight-Swift stock price fell over 7.1% to close at $44.01 per share on October 23, 2025.
If you suffered a loss on your Knight-Swift Transportation Holdings Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Lennox International Inc. (NYSE: LII) concerning potential violations of the federal securities laws.
On October 22, 2025, Lennox published mixed third quarter 2025 financial results. Particularly, the Company disclosed that it faced a number of challenges including revenue declines and inventory issues, which resulted in a full-year guidance revision. Following this news, Lennox’s stock price fell over 55.9% to close at $493.07 per share on October 22, 2025.
If you suffered a loss on your Lennox International Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Sonic Automotive, Inc. (NYSE: SAH) concerning potential violations of the federal securities laws.
Sonic Automotive reported its financial results for the third quarter of 2025 on October 23, 2025. Among other items, Sonic Automotive reported a 33% decline in net income, which the Company attributed to a significant increase in medical expenses and a higher effective income tax rate during the quarter. Following this news, Sonic Automotive's stock price fell over 15% on October 23, 2025.
If you suffered a loss on your Sonic Automotive, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Protalix BioTherapeutics, Inc. (NYSE: PLX) concerning potential violations of the federal securities laws.
On October 17, 2025, Protalix and Chiesi Global Rare Diseases, Protalix's partner in "the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system", issued a press release "acknowledging that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a negative opinion on the request to approve the dosing regimen of 2 mg/kg body weight infused every 4 weeks (E4W) for Elfabrio (pegunigalsidase alfa, in addition to the currently approved dosing regimen of 1 mg/kg body weight infused every 2 weeks (E2W)." Following this news, Protalix's stock price fell over 22% on October 17, 2025.
If you suffered a loss on your Protalix BioTherapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Alector, Inc. (NASDAQ: ALEC) concerning potential violations of the federal securities laws.
On October 22, 2025, Alector announced results from its Phase 2 INFRONT-3 clinical trial evaluating latozinemab (AL001) in patients with frontotemporal dementia due to a progranulin gene mutation (FTD-GRN). The company reported that “latozinemab did not demonstrate a clinical benefit” for slowing FTD-GRN progression in its 96-week double-blind trial. Following this news, ALEC’s stock price fell over 52% to open at $1.54 per share.
If you suffered a loss on your Alector, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Tvardi Therapeutics, Inc. (NASDAQ: TVRD) concerning potential violations of the federal securities laws.
On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing its STAT3 inhibitor drug, TTI-101, to treat patients with idiopathic pulmonary fibrosis (IPF). The company reported that “the study did not meet its goals,” as the “[p]reliminary analysis of exploratory efficacy showed no statistically significant differences between placebo and treatment arms.” Management also highlighted significant discontinuation rates of more than 56% in both treatment arms compared to only 10.3% in the placebo group. Following this news, Tvardi’s stock price fell by $34.91 per share to close at $6.69 per share.
If you suffered a loss on your Tvardi Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Trinseo PLC (NYSE: TSE) concerning potential violations of the federal securities laws.
Trinseo announced on October 6, 2025, that it is indefinitely suspending its quarterly dividend and permanently closing its methyl methacrylate production operations in Rho, Italy, and its acetone cyanohydrin production operations in Porto Marghera, Italy. Trinseo said that its actions are aimed at further optimizing its operations, enhancing cash flow generation and strengthening long-term profitability. Following this news, Trinseo's stock price fell over 12% on October 7, 2025.
If you suffered a loss on your Trinseo PLC securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Western Alliance Bancorporation (NYSE: WAL) concerning potential violations of the federal securities laws.
Western Alliance Bancorporation disclosed on October 16, 2025, that it had initiated a lawsuit against a borrower, Cantor Group V LLC, alleging fraud related to collateral loans. Following this news, Western Alliance stock fell over 10% on the same day.
If you suffered a loss on your Western Alliance Bancorporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Larimar Therapeutics, Inc. (NASDAQ: LRMR) concerning potential violations of the federal securities laws.
Larimar issued a press release on September 29, 2025, announcing data from an ongoing long-term open-label study evaluating daily subcutaneous injections of Nomlabofusp in participants with Friedreich's Ataxia. Although Larimar characterized the data as "positive", the press release disclosed that anaphylaxis or a severe allergic reaction was reported in seven participants. Following this news, Larimar's stock price fell over 33% on September 29, 2025.
If you suffered a loss on your Larimar Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Organogenesis Holdings Inc. (NASDAQ: ORGO) concerning potential violations of the federal securities laws.
Organogenesis issued a press release on September 25, 2025, disclosing that a second phase 3 trial of its cryopreserved amniotic suspension allograft ReNu missed its primary endpoint, having failed to achieve a significantly significant change in pain reduction. The Company said it would ask for a pre-Biologics License Application (BLA) meeting with the U.S. Food and Drug Administration by the end of October to examine a submission pathway, "including using the combined efficacy analysis from both Phase 3 studies to support a BLA approval," according to Chief Operating Officer Patrick Bilbo. Following this news, Organogenesis's stock price fell over 12% on September 26, 2025.
If you suffered a loss on your Organogenesis Holdings Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Palantir Technologies Inc. (NASDAQ: PLTR) concerning potential violations of the federal securities laws.
Media outlets reported on October 3, 2025, that an internal U.S. Army memo described the NGC2 platform - a battlefield communication system developed by Palantir and Anduril Industries - as a "very high risk" due to security vulnerabilities that could allow adversaries to gain "persistent undetectable access" to the system. Following this news, Palantir's stock price fell over 7% on October 3, 2025.
If you suffered a loss on your Palantir Technologies Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Americas Car-Mart, Inc. (NASDAQ: CRMT) concerning potential violations of the federal securities laws.
Car-Mart disclosed on July 15, 2025, it would delay filing its annual report because "management identified the need to enhance disclosures related to loan modifications for borrowers experiencing financial difficulty." Due to this news, Car-Mart's stock price dropped. On July 30, 2025, the Company disclosed that it had "concluded that certain previously issued financial statements should no longer be relied upon," due to omissions in "disclosure related to loan modifications made to borrowers experiencing financial difficulty" including the "qualitative and quantitative information about the types of modifications utilized by the Company," "the financial effect of the modification by type of modification," "receivable performance in the 12 months after a modification." On September 4, 2025, Car-Mart released its first quarter fiscal 2025 financial results, revealing that "sales volumes declined 5.7% to 13,568 units compared to 14,391 in the prior year," which the Company attributed to "[prioritizing] booking the Company's strongest-performing customer rankings" and "vehicle quality aimed at controlling repair costs downstream and selling to a better credit quality customer." Following this news, Car-Mart's stock price dropped.
If you suffered a loss on your America's Car-Mart, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Rezolve AI PLC (NASDAQ: RZLV) concerning potential violations of the federal securities laws.
Investing.com published an article on September 29, 2025, entitled "Rezolve AI faces short seller allegations of deceptive practices." The article stated that Fuzzy Panda Research had "announced a short position in Rezolve AI," based on the claim that Rezolve "is misrepresenting its artificial intelligence capabilities and revenue growth." Following this news, Rezolve stock dropped over 10% on September 29, 2025.
If you suffered a loss on your Rezolve AI PLC securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Brunello Cucinelli S.p.A. (OTC: BCUCY) concerning potential violations of the federal securities laws.
Morpheus Research published a report on September 25, 2025, entitled "From Moscow to TJ Maxx - How Brunello Cucinelli Continues To Lie About Its Russian Business While Aggressive Discounting Damages Its Exclusive Positioning." The report discussed how Brunello Cucinelli had represented that its Russian store locations were shut, which was consistent with laws prohibiting the sale of luxury goods in Russia after its invasion of Ukraine. Contrary to this representation, the report claimed, Brunello Cucinelli continued to conduct business in Russia. Following this news, Brunello Cucinelli American Depositary Receipts dropped over 17% on the same day.
If you suffered a loss on your Brunello Cucinelli S.p.A. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The Hain Celestial Group, Inc. (NASDAQ: HAIN) concerning potential violations of the federal securities laws.
Hain issued a press release on September 15, 2025, reporting its financial results for the fourth quarter and fiscal year 2025. Acknowledging Hain's disappointing results, the Company's interim Chief Executive Officer said that "[w]e are taking decisive action to optimize cash, deleverage our balance sheet, stabilize sales, and improve profitability as we recognize our performance has not met expectations[.]" Following this news, Hain's stock price fell over 24% on September 15, 2025.
If you suffered a loss on your The Hain Celestial Group, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Stride, Inc. (NYSE: LRN) concerning potential violations of the federal securities laws.
Simply Wall St. published a report on September 14, 2025, stating that the Gallup-McKinley County Schools Board of Education had filed a complaint against Stride, alleging fraud, deceptive trade practices, systemic violations of law, and intentional and tortious misconduct, including inflating enrollment numbers by retaining "ghost students" on rolls to secure state funding per student and ignoring compliance requirements, including background checks and licensure laws for its employees. On this news, Stride's stock price dropped.
If you suffered a loss on your Stride, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Amer Sports, Inc. (NYSE: AS) concerning potential violations of the federal securities laws.
On September 19, 2025, Amer's flagship brand Arc'teryx conducted a promotional fireworks display in Tibet, prompting a backlash from environmentalists and triggering an investigation by Chinese authorities. Following this, Amer's stock price subsequently fell over 5% on September 22, 2025.
If you suffered a loss on your Amer Sports, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





